Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Allylic Substitution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103896816B details iridium-catalyzed synthesis offering high enantioselectivity and scalable production for pharmaceutical intermediates.
Patent CN102167674A details a mild iridium-catalyzed method for synthesizing optically pure 3-aryl sulfur-substituted propenes, offering significant supply chain advantages.
Patent CN121085785A reveals ferrocene-based ligands for asymmetric allylic substitution, offering high enantioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN116730993A reveals a novel Ir-catalyzed route for Teranavir. Achieve high-purity HIV protease inhibitors with reduced steps and cost reduction in API manufacturing.
Patent CN107286075A reveals efficient Pd-catalyzed route. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel imidazolium-functionalized ferrocene ligands enable high-yield asymmetric allylic substitution with recyclable catalyst properties for pharmaceutical intermediates.
Novel biaryl ligand synthesis via Catellani reaction offers high enantioselectivity and scalable routes for pharmaceutical intermediates.
Patent CN111718372B discloses a novel axial chiral ligand enabling high-yield asymmetric allylic substitution with simplified synthesis for cost-effective API manufacturing.
Patent CN111718372B discloses a novel axial chiral ligand enabling high-yield asymmetric allylic substitution with excellent enantioselectivity for cost-effective API manufacturing.
Patent CN111718372B enables high-purity fine chemical production through innovative ligand technology with reduced lead time and scalable manufacturing solutions for pharmaceutical intermediates.